Brugada syndrome (BrS) is a rare disorder characterized by coved or saddle-shaped ST-
segment elevation in the right precordial leads on the electrocardiogram. Risk stratification …

Abstract Background Brugada Syndrome (BrS) is a life-threatening cardiac arrhythmia
disorder associated with an increased risk of ventricular arrhythmias (VAs) and sudden …

BACKGROUND: A pathogenic/likely pathogenic variant can be found in 20% to 25% of
patients with Brugada syndrome (BrS) and a pathogenic/likely pathogenic variant in SCN5A …

Aims A pathogenic/likely pathogenic (P/LP) variant in SCN5A is found in 20–25% of patients
with Brugada syndrome (BrS). However, the diagnostic yield and prognosis of gene panel …

Background The rate of sudden cardiac death (SCD) in Brugada syndrome (BrS) is≈ 1%/y.
Noninvasive electrocardiographic imaging is a noninvasive mapping system that has a role …

Background: In the field of medicine, photogrammetry has played for long time a marginal
role due to the significant amount of work required that made it impractical for an extended …

Abstract Background Patients with Brugada syndrome (BrS) have an increased risk of
arrhythmias, including atrial tachyarrhythmias (ATas). Objectives The purpose of this study …

Purpose Drug-induced type I Brugada syndrome (BrS) is associated with a ventricular
arrhythmia (VA) rate of 1 case per 100 person-years. This study aims to evaluate changes in …

Background Brugada syndrome (BrS) is caused by mutations in SCN5A gene in 15%-20%
of cases. Previous studies showed worse prognosis in SCN5A mutation carriers (SCN5A+) …

Introduction Predictors of late life-threatening arrhythmic events in Brugada syndrome (BrS)
patients who received a prophylactic ICD implantation remain to be evaluated. The aim of …